BOSTON--(BUSINESS WIRE)--The cognitive science company, Cogstate, today announced that its Healthcare Division has received CE Mark approval for its Cognigram TM digital cognitive assessment system.

NEW HAVEN, Conn.--(BUSINESS WIRE)--The cognitive science company, Cogstate Ltd (ASX:CGS) today announced it has been chosen as the preferred provider to the global healthcare leader, Eli Lilly and ...

Biopharma sponsors and CROs now have access to a modern eCOA solution that seamlessly integrates a configurable, no-code platform with validated cognitive assessments and deep clinical expertise ...

Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cogstate, a leading neuroscience technology company, today announced the appointment ...

Melbourne, VIC, Australia; New Haven, CT, USA, June 14, 2022 (GLOBE NEWSWIRE) -- Cogstate (ASX.CGS) a leading neuroscience technology company, today announced the formation of a Scientific Advisory ...

Eisai Co., Ltd. and Cogstate, Ltd. announced that the companies have entered into a collaboration whereby Eisai has secured the global development rights and exclusive commercialization rights of all ...

Melbourne, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today the appointment of Chris Edgar, PhD as Chief Science Officer and Prof. Paul Maruff ...

Hello, everyone, and welcome to today's webinar unlocking sustainable clinical trials growth, which is part of the Cogstate Investor Insight series. I'm pleased to introduce our panelists today, Brad ...

Clinical research and health tech companies Medidata and Cogstate are joining forces to speed up trials and improve outcomes measurement across diseases of the central nervous system, the partners ...

decentralized research and electronic clinical outcome assessment (eCOA) provider, today announced a collaboration with cognitive science leaders Cogstate Limited (ASX:CGS). The partnership combines ...